Finoriq research workspace
BELITE BIO, INC (BLTE) Historical Metrics
Review reported fundamentals, derived ratios, valuation context, and historical charts for BELITE BIO, INC (BLTE).
Company Snapshot
- Company
- BELITE BIO, INC (BLTE)
- Ticker
- BLTE
- Market Cap
- $6B
- Latest Price
- $153.63
- Industry
- Biotech & Pharma
BELITE BIO, INC (BLTE) Current Valuation Metrics
Static valuation preview for BELITE BIO, INC (BLTE). Market data retrieved 2026-07-08. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -1.3% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -0.62% | Operating Cash Flow | TTM FY 2025 |
| Price / BookMarket cap divided by stockholders' equity. | 7.75x | Stockholders' Equity | FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.